X

Xeris Biopharma Holdings

D
XERS
USD
0.135
(4.0119%)
مفتوح الان
252,603.00
حجم التداول
-0.325
الربح لكل سهم
-
العائد الربحي
-8.333333
P/E
521,495,887.50
حجم السوق
اليوم
4.0119%
1 اسبوع
8.192%
1 شهر
19.658%
6 اشهر
85.185%
12 اشهر
87.166%
بداية السنة
48.305%
كل الوقت
0%

Title:
Xeris Biopharma Holdings

Sector:
Healthcare
Industry:
Biotechnology
Xeris Biopharma Holdings Inc is a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology, neurology, and gastroenterology. The company has three commercially available products, Gvoke, ready-to-use liquid glucagon for the treatment of severe hypoglycemia, Keveyis, the first FDA-approved therapy for primary periodic paralysis, and Recorlev, approved by the FDA for the treatment of endogenous hypercortisolemia in adult patients with Cushing's Syndrome. The Company also has a pipeline of development programs to bring new products forward using its proprietary formulation science, XeriSol and XeriJect.
هل تحتاج مساعدة او لديك استفسار؟